» Articles » PMID: 37947597

Ferritin Is Secreted from Primary Cultured Astrocyte in Response to Iron Treatment Via TRPML1-Mediated Exocytosis

Overview
Journal Cells
Publisher MDPI
Date 2023 Nov 10
PMID 37947597
Authors
Affiliations
Soon will be listed here.
Abstract

Impaired iron homeostasis has been proven to be one of the critical contributors to the pathology of Parkinson's disease (PD). Ferritin is considered an intracellular protein responsible for storing cytosolic iron. Recent studies have found that ferritin can be secreted from cells independent of the classical endoplasmic reticulum-Golgi system. However, the precise mechanisms underlying the secretion of ferritin in the brain were not elucidated. In the present study, we demonstrated that the primary cultured astrocytes do have the ability to secrete ferritin, which is enhanced by iron treatment. Increased ferritin secretion was accompanied by increased protein expression of ferritin response to iron stimulation. Further study showed that iron-induced expression and secretion of ferritin could be inhibited by CQ or 3-MA pretreatment. In addition, the knockdown of transient receptor potential mucolipin 1 (TRPML1) antagonized iron-induced ferritin secretion, accompanied by further increased intracellular protein levels of ferritin. Further study demonstrated that ferritin colocalized with LAMP1 in iron-treated astrocytes. On the contrary, ras-associated protein 27a (Rab27a) knockdown further enhanced iron-induced ferritin secretion and decreased intracellular protein levels of ferritin. Furthermore, we also showed that the secretory autophagy protein tripartite motif containing 16 (TRIM16) and sec22b decreased in iron-treated astrocytes. These results suggested that astrocytes might secrete ferritin via TRPML1-mediated exocytosis. This provides new evidence for the mechanisms underlying the secretion of ferritin in primary cultured astrocytes under a high iron environment.

Citing Articles

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.

Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X Signal Transduct Target Ther. 2025; 10(1):31.

PMID: 39894843 PMC: 11788444. DOI: 10.1038/s41392-024-02071-0.


Glial cells improve Parkinson's disease by modulating neuronal function and regulating neuronal ferroptosis.

Li M, Chen M, Li H, Gao D, Zhao L, Zhu M Front Cell Dev Biol. 2025; 12():1510897.

PMID: 39830208 PMC: 11739109. DOI: 10.3389/fcell.2024.1510897.


Chelerythrine triggers the prolongation of QT interval and induces cardiotoxicity by promoting the degradation of hERG channels.

Wang F, Wang B, Gu X, Li X, Liu X, Li B J Biol Chem. 2024; 301(1):108023.

PMID: 39608718 PMC: 11721429. DOI: 10.1016/j.jbc.2024.108023.


Bile from the hemojuvelin-deficient mouse model of iron excess is enriched in iron and ferritin.

Prajapati M, Chiu L, Zhang J, Chong G, DaSilva N, Bartnikas T Metallomics. 2024; 16(10).

PMID: 39313333 PMC: 11459263. DOI: 10.1093/mtomcs/mfae043.

References
1.
Singh C, Roy-Chowdhuri S . Quantitative Real-Time PCR: Recent Advances. Methods Mol Biol. 2016; 1392:161-76. DOI: 10.1007/978-1-4939-3360-0_15. View

2.
Ismail A, Lachlan K, Mumford A, Temple I, Hodgkins P . Hereditary hyperferritinemia cataract syndrome: ocular, genetic, and biochemical findings. Eur J Ophthalmol. 2006; 16(1):153-60. DOI: 10.1177/112067210601600125. View

3.
Zecca L, Youdim M, Riederer P, Connor J, Crichton R . Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004; 5(11):863-73. DOI: 10.1038/nrn1537. View

4.
Wilkinson N, Pantopoulos K . The IRP/IRE system in vivo: insights from mouse models. Front Pharmacol. 2014; 5:176. PMC: 4112806. DOI: 10.3389/fphar.2014.00176. View

5.
Greco T, Seeholzer S, Mak A, Spruce L, Ischiropoulos H . Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion. J Proteome Res. 2010; 9(5):2764-74. PMC: 2866110. DOI: 10.1021/pr100134n. View